134 related articles for article (PubMed ID: 15796261)
21. A refugee with a supraclavicular lymph node. An uncommon first presentation of carcinoma of the prostate.
Bossink AW; Rabe KF
Neth J Med; 2001 Jan; 58(1):22-6. PubMed ID: 11137747
[TBL] [Abstract][Full Text] [Related]
22. Prostate carcinoma metastatic to the cervical lymph nodes: report of two cases and review of the literature.
Copeland B; Clark JM; Sura A; Kilpatrick SE; Shockley W; Meredith S
Am J Otolaryngol; 2001; 22(6):420-3. PubMed ID: 11713729
[TBL] [Abstract][Full Text] [Related]
23. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
24. Metastatic prostatic carcinoma presenting as left-sided cervical lymphadenopathy: a series of 11 cases.
Jones H; Anthony PP
Histopathology; 1992 Aug; 21(2):149-54. PubMed ID: 1505932
[TBL] [Abstract][Full Text] [Related]
25. Advanced carcinoma of the prostate presenting as a supraclavicular mass: case report.
Agbugui JO; Obarisiagbon EO; Ugiagbe EE
Niger Postgrad Med J; 2014 Sep; 21(3):269-71. PubMed ID: 25331247
[TBL] [Abstract][Full Text] [Related]
26. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
27. CT evaluation of lymph node status at presentation of prostatic carcinoma.
Spencer J; Golding S
Br J Radiol; 1992 Mar; 65(771):199-201. PubMed ID: 1547445
[TBL] [Abstract][Full Text] [Related]
28. [Left supraclavicular adenopathy with a neuroendocrine pattern of unknown cause: prostatic carcinoma metastasis].
Fernández Borrell A; Peinado Ibarra F; Gómez Sancha F; Teba del Pino F; Minguez Martínez R; Morato Robert P; Arellano Gañan R; Romero Tejada JC; Pereira Sanz I
Actas Urol Esp; 1999; 23(7):603-8. PubMed ID: 10488615
[TBL] [Abstract][Full Text] [Related]
29. The value of prostate-specific antigen levels in pelvic lymph nodes for diagnosing metastatic spread of prostate cancer.
Shoskes DA; Trachtenberg J
Can J Surg; 1993 Feb; 36(1):33-6. PubMed ID: 7680271
[TBL] [Abstract][Full Text] [Related]
30. Prostate adenocarcinoma presenting with inguinal lymphadenopathy.
Huang E; Teh BS; Mody DR; Carpenter LS; Butler EB
Urology; 2003 Feb; 61(2):463. PubMed ID: 12597980
[TBL] [Abstract][Full Text] [Related]
31. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
[TBL] [Abstract][Full Text] [Related]
33. Predicting pelvic lymph node involvement in current-era prostate cancer.
Rahman S; Cosmatos H; Dave G; Williams S; Tome M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478
[TBL] [Abstract][Full Text] [Related]
34. Is systematic scalene node biopsy in pretreatment evaluation of locally advanced cervical carcinoma necessary? Systematic dissection and histopathology of left scalene node biopsies in patients with locally advanced cervical carcinoma.
Samouëlian V; Baranzelli MC; Narducci F; Taïeb S; Cabaret V; Querleu D; Leblanc E
Gynecol Oncol; 2006 Dec; 103(3):1091-4. PubMed ID: 16890275
[TBL] [Abstract][Full Text] [Related]
35. Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report.
Zhu L; Luo C; Wu W; Ying J; Zhong H
J Res Med Sci; 2013 Sep; 18(9):814-7. PubMed ID: 24381627
[TBL] [Abstract][Full Text] [Related]
36. Neck mass as the first presentation of metastatic prostatic adenocarcinoma.
Lin YY; Lin DS; Kang BH; Lin YS
J Chin Med Assoc; 2011 Dec; 74(12):570-3. PubMed ID: 22196474
[TBL] [Abstract][Full Text] [Related]
37. Generalized lymphadenopathy: a rare presentation of disseminated prostate cancer.
Oyan B; Engin H; Yalcin S
Med Oncol; 2002; 19(3):177-9. PubMed ID: 12482129
[TBL] [Abstract][Full Text] [Related]
38. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
39. [A case of prostate cancer diagnosed by lymphadenectomy].
Fukumoto R; Soda T; Uehara M; Hayashi T; Oka D; Fujimoto N; Koide T
Hinyokika Kiyo; 2012 Oct; 58(10):557-60. PubMed ID: 23235279
[TBL] [Abstract][Full Text] [Related]
40. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
